Lombard Medical Company Profile (NASDAQ:EVAR)

About Lombard Medical (NASDAQ:EVAR)

Lombard Medical logoLombard Medical, Inc. is a medical technology company. The Company specializes in developing, manufacturing, and marketing endovascular stent-grafts that address medical needs in the repair of aortic aneurysms. The Company's Aorfix is an abdominal aortic aneurysm (AAA) stent-graft for the treatment of AAAs with angulation at the neck of the aneurysm of over 90 degrees. The Company supplies Aorfix pre-loaded into a delivery system, Aorflex, which is designed for accurate placement of Aorfix in the abdominal aorta. Once Aorfix is properly placed within the abdominal aorta, it provides a conduit for blood flow, thereby relieving pressure within the weakened or aneurysmal section of the vessel wall, which reduces the potential for the AAA to rupture. It also offers IntelliFlex, which is a delivery system technology created for Aorfix AAA stent graft, and Altura Endovascular Stent Graft System that offers a simple and predictable solution to the treatment of standard AAA anatomies.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Equipment, Supplies & Distribution - NEC
  • Sub-Industry: N/A
  • Symbol: NASDAQ:EVAR
  • CUSIP: N/A
  • Web: www.lombardmedical.com
  • Market Cap: $11.73 million
  • Outstanding Shares: 27,950,000
Average Prices:
  • 50 Day Moving Avg: $0.52
  • 200 Day Moving Avg: $0.58
  • 52 Week Range: $0.40 - $1.49
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.46
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $12.17 million
  • Price / Sales: 1.24
  • Book Value: $0.50 per share
  • Price / Book: 1.08
  • EBIDTA: ($24,220,000.00)
  • Net Margins: -255.03%
  • Return on Equity: -124.24%
  • Return on Assets: -41.26%
  • Debt-to-Equity Ratio: 2.01%
  • Current Ratio: 3.33%
  • Quick Ratio: 2.65%
  • Average Volume: 44,118 shs.
  • Beta: 1.23
  • Short Ratio: 1.36
Frequently Asked Questions for Lombard Medical (NASDAQ:EVAR)

What is Lombard Medical's stock symbol?

Lombard Medical trades on the NASDAQ under the ticker symbol "EVAR."

How were Lombard Medical's earnings last quarter?

Lombard Medical, Inc. (NASDAQ:EVAR) announced its quarterly earnings results on Thursday, October, 27th. The company reported ($0.37) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by $0.11. The business earned $3.04 million during the quarter, compared to analysts' expectations of $3.16 million. Lombard Medical had a negative net margin of 255.03% and a negative return on equity of 124.24%. View Lombard Medical's Earnings History.

Where is Lombard Medical's stock going? Where will Lombard Medical's stock price be in 2017?

2 brokerages have issued 12-month price targets for Lombard Medical's shares. Their predictions range from $1.00 to $1.00. On average, they expect Lombard Medical's stock price to reach $1.00 in the next twelve months. View Analyst Ratings for Lombard Medical.

Who are some of Lombard Medical's key competitors?

Who are Lombard Medical's key executives?

Lombard Medical's management team includes the folowing people:

  • Simon Hubbert, Chief Executive Officer, Director
  • William J. Kullback, Chief Financial Officer
  • Peter Phillips, Chief Technology Officer
  • Raymond Wayne Cohen, Non-Executive Independent Chairman of the Board
  • David B. Milne, Director
  • Michael H. Carrel, Non-Executive Director
  • Timothy Haines, Independent Director
  • Simon John Neathercoat, Senior Independent Director

How do I buy Lombard Medical stock?

Shares of Lombard Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Lombard Medical's stock price today?

One share of Lombard Medical stock can currently be purchased for approximately $0.54.

MarketBeat Community Rating for Lombard Medical (NASDAQ EVAR)
Community Ranking:  3.1 out of 5 (  )
Outperform Votes:  53 (Vote Outperform)
Underperform Votes:  33 (Vote Underperform)
Total Votes:  86
MarketBeat's community ratings are surveys of what our community members think about Lombard Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Lombard Medical (NASDAQ:EVAR) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $1.00 (85.19% upside)

Analysts' Ratings History for Lombard Medical (NASDAQ:EVAR)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
8/23/2016BTIG ResearchReiterated RatingHoldN/AView Rating Details
8/23/2016Barclays PLCLower Price TargetEqual Weight$2.50 -> $1.00N/AView Rating Details
7/28/2015Jefferies Group LLCLower Price TargetBuy$7.50 -> $6.00N/AView Rating Details
(Data available from 7/26/2015 forward)


Earnings History for Lombard Medical (NASDAQ:EVAR)
Earnings by Quarter for Lombard Medical (NASDAQ:EVAR)
Earnings History by Quarter for Lombard Medical (NASDAQ EVAR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/27/2016Q3($0.27)($0.37)$3.16 million$3.04 millionViewN/AView Earnings Details
8/22/2016Q2145($0.40)($0.42)$3.78 million$3.80 millionViewListenView Earnings Details
5/11/2016Q1($0.41)($0.38)$3.52 million$2.90 millionViewListenView Earnings Details
2/22/2016Q415($0.40)($0.58)$3.25 million$2.94 millionViewListenView Earnings Details
11/4/2015Q315($0.53)($0.45)$4.65 million$4.20 millionViewN/AView Earnings Details
7/27/2015Q215($0.55)($0.51)$4.46 million$4.54 millionViewListenView Earnings Details
5/11/2015Q1145($0.57)($0.59)$3.20 million$3.41 millionViewListenView Earnings Details
2/26/2015Q4($0.46)($0.51)$4.80 million$4.80 millionViewN/AView Earnings Details
10/29/2014Q314($0.79)($0.52)$2.14 million$4.30 millionViewN/AView Earnings Details
8/11/2014Q2 2014($0.52)($0.86)$2.40 million$2.19 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Lombard Medical (NASDAQ:EVAR)
Current Year EPS Consensus Estimate: $-0.61 EPS
Next Year EPS Consensus Estimate: $-0.37 EPS


Dividend History for Lombard Medical (NASDAQ:EVAR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Lombard Medical (NASDAQ:EVAR)
No insider trades for this company have been tracked by MarketBeat.com


Headline Trends for Lombard Medical (NASDAQ:EVAR)
Latest Headlines for Lombard Medical (NASDAQ:EVAR)
finance.yahoo.com logoLombard Medical, Inc. :EVAR-US: Earnings Analysis: Q4, 2016 By the Numbers : May 26, 2017
finance.yahoo.com - May 26 at 5:44 PM
finance.yahoo.com logoLombard Medical Announces First Patient Enrolled and Treated in the ALTITUDE Registry for the Altura® Stent Graft System
finance.yahoo.com - May 15 at 11:37 AM
americanbankingnews.com logoShort Interest in Lombard Medical Inc (EVAR) Grows By 28.7%
www.americanbankingnews.com - May 14 at 9:14 AM
finanznachrichten.de logoLombard Medical's Endovascular Product Portfolio Presented at Scientific Sessions of the 39th Annual Charing Cross International Symposium
www.finanznachrichten.de - May 5 at 3:16 AM
finance.yahoo.com logoLombard Medical’s Endovascular Product Portfolio Presented at Scientific Sessions of the 39th Annual Charing Cross International Symposium
finance.yahoo.com - May 4 at 12:11 PM
americanbankingnews.com logoLombard Medical (EVAR) Receiving Somewhat Negative News Coverage, Study Shows
www.americanbankingnews.com - May 2 at 5:20 PM
americanbankingnews.com logoLombard Medical (EVAR) Receives Daily News Impact Rating of 0.56
www.americanbankingnews.com - April 27 at 8:58 AM
americanbankingnews.com logoLombard Medical (EVAR) Given News Impact Rating of 0.28
www.americanbankingnews.com - April 22 at 2:49 PM
streetinsider.com logoLombard Medical (EVAR) Names Kurt Lemvigh as CEO
www.streetinsider.com - April 20 at 10:09 PM
finance.yahoo.com logoLombard Medical Appoints New CEO
finance.yahoo.com - April 20 at 5:09 PM
americanbankingnews.com logoSomewhat Favorable Media Coverage Very Unlikely to Affect Lombard Medical (EVAR) Share Price
www.americanbankingnews.com - April 19 at 11:35 AM
finance.yahoo.com logoLombard Medical’s CEO Steps Down
finance.yahoo.com - April 18 at 11:48 AM
finance.yahoo.com logoLombard Medical Reports 2016 Fourth Quarter, Full Year Financial Results
finance.yahoo.com - April 18 at 11:48 AM
finance.yahoo.com logoLombard Medical reports 4Q loss
finance.yahoo.com - April 18 at 11:48 AM
americanbankingnews.com logoLombard Medical Inc (EVAR) to Release Quarterly Earnings on Monday
www.americanbankingnews.com - April 7 at 8:55 PM
americanbankingnews.com logoLombard Medical Inc (EVAR) Scheduled to Post Quarterly Earnings on Friday
www.americanbankingnews.com - March 30 at 7:05 AM
finance.yahoo.com logoLombard Medical Announces Successful Completion of First 15 Cases in Japan for IntelliFlex™ LP Delivery System for the Aorfix™ Endovascular Stent Graft
au.finance.yahoo.com - February 7 at 6:17 PM
us.rd.yahoo.com logoLombard Medical Announces Regulatory Approval in Japan for IntelliFlex™ LP Delivery System for the Aorfix™ Abdominal Aortic Aneurysm Endovascular Stent Graft
us.rd.yahoo.com - January 6 at 5:37 PM
finance.yahoo.com logoEVAR: $15M Investment, Additional Positive Outcomes Data
finance.yahoo.com - December 23 at 5:19 PM
benzinga.com logoPositive Long-Term Data for Lombard Medical'...
www.benzinga.com - December 5 at 5:44 PM
us.rd.yahoo.com logoPositive Long-Term Data for Lombard Medical’s Aorfix™ Endovascular Stent Graft System Confirms Sustained Performance in the Most Challenging Anatomies
us.rd.yahoo.com - December 5 at 11:44 AM
us.rd.yahoo.com logo6:01 am Lombard Medical announces 'positive' long-term data for its Aorfix endovascular stent graft system at the VEITHsymposium
us.rd.yahoo.com - December 5 at 11:44 AM
globenewswire.com logoUK - Manchester Group of Hospitals presented early experience and 100% technical success in 24 patients treated with Altura
globenewswire.com - November 22 at 8:08 AM
streetinsider.com logoForm 6-K Lombard Medical, Inc. For: Nov 21
www.streetinsider.com - November 22 at 8:08 AM
streetinsider.com logoLombard Medical (EVAR) Receives Nasdaq Listing Notification
www.streetinsider.com - November 16 at 5:05 PM
finance.yahoo.com logoEVAR: Benefits From IntelliFlex, Sales Reorg Not Yet Fully Realized
finance.yahoo.com - November 1 at 5:05 PM
finance.yahoo.com logoEVAR: Exiting Underperforming U.S. Market and Seeking 'Strategic Alternatives'
finance.yahoo.com - August 24 at 4:51 PM
finance.yahoo.com logoEdited Transcript of EVAR earnings conference call or presentation 22-Aug-16 8:30pm GMT
finance.yahoo.com - August 23 at 9:15 AM
biz.yahoo.com logoQ2 2016 Lombard Medical Inc Earnings Release - After Market Close
biz.yahoo.com - August 22 at 9:35 AM
baystreet.ca logoDurable Goods, Wholesale Trade, on Next Week’s Docket
www.baystreet.ca - August 19 at 4:52 PM
nasdaq.com logoLombard Medical Reschedules 2016 Second Quarter, Six-Month Financial Results Release and Conference
www.nasdaq.com - August 12 at 4:57 PM
globenewswire.com logoIntelliFlex LP’s Lower Catheter Profile Expands Aorfix Treatment to More Patients
globenewswire.com - July 1 at 4:54 PM
nasdaq.com logoIntelliFlex LP's Lower Catheter Profile Expands Aorfix Treatment to More Patients
www.nasdaq.com - June 30 at 10:22 PM
globenewswire.com logoLombard Medical Announces First Commercial Use of its New IntelliFlex™ LP Delivery System for the Aorfix ... - GlobeNewswire (press release)
globenewswire.com - June 30 at 7:30 AM
globenewswire.com logoNew, Innovative Design Enhances Control and Precision During Placement with the Potential to Reduce Vessel Trauma
globenewswire.com - June 20 at 4:47 PM
globenewswire.com logoPaul Hayes, MD, FRCS, Endovascular Surgeon, University of Cambridge and Addenbrookes Hospital, Appointed as Principal Investigator
globenewswire.com - June 16 at 9:16 AM
streetinsider.com logoLombard Medical (EVAR) Offers Commercial Update on Altura Endovascular Stent Graft System
www.streetinsider.com - June 9 at 8:27 AM
finance.yahoo.com logo6:10 am Lombard Medical provides update on Altura Endovascular Stent Graft System, EU launch planned in 3Q16, long-term clinical data to be released in second half of 2016
finance.yahoo.com - June 8 at 6:10 AM
globenewswire.com logoLombard Medical to Present at the Jefferies 2016 Healthcare Conference - GlobeNewswire (press release)
globenewswire.com - June 7 at 5:00 PM



Lombard Medical (EVAR) Chart for Wednesday, July, 26, 2017

This page was last updated on 7/26/2017 by MarketBeat.com Staff